Tag Archives: ESRX

Hot Financial Stocks To Invest In Right Now

SSR Mining Inc. (TSE:SSRM) shares hit a new 52-week high on Wednesday . The company traded as high as C$13.45 and last traded at C$13.40, with a volume of 87157 shares trading hands. The stock had previously closed at C$13.16.

A number of research analysts have weighed in on the company. National Bank Financial decreased their price objective on SSR Mining from C$18.00 to C$17.75 in a report on Friday, May 11th. Canaccord Genuity raised their price objective on SSR Mining from C$21.00 to C$22.00 in a report on Monday, April 23rd. Five research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of C$16.18.

In other news, insider Jonathan Gilligan sold 27,875 shares of SSR Mining stock in a transaction on Friday, March 2nd. The stock was sold at an average price of C$7.17, for a total transaction of C$199,863.75. Also, Director Paul Benson purchased 10,000 shares of SSR Mining stock in a transaction dated Tuesday, March 13th. The shares were bought at an average price of C$11.62 per share, for a total transaction of C$116,200.00.

Hot Financial Stocks To Invest In Right Now: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Brinker Capital Inc. increased its position in Express Scripts (NASDAQ:ESRX) by 11.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,842 shares of the company’s stock after purchasing an additional 8,605 shares during the quarter. Brinker Capital Inc.’s holdings in Express Scripts were worth $5,861,000 at the end of the most recent quarter.

  • [By ]

    The space that could come under the most pressure are the pharmacy benefit management players, an industry that thrives on the rebate system. Stocks to watch include: CVS Health (CVS) (owns PBM Caremark) and Express Scripts (ESRX) (and by extension Cigna (CI) , which is trying to acquire Express Scripts).

  • [By Logan Wallace]

    Schaper Benz & Wise Investment Counsel Inc. WI cut its holdings in shares of Express Scripts (NASDAQ:ESRX) by 2.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 85,515 shares of the company’s stock after selling 1,770 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Express Scripts were worth $5,907,000 at the end of the most recent quarter.

  • [By Alexander Bird]

    Both CVS Health Corp. (NYSE: CVS) and Cigna Corp. (NYSE: CI) sank 5% while Express Scripts Holding Co. (NASDAQ: ESRX), one of the primary providers of pharmacy benefits, dropped 9.7% in response to the disruptive impact the announced partnership could have on the industry. Altogether, the healthcare sector lost a combined $30 billion in market share in the first two hours of trading today.

  • [By Cory Renauer]

    Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.

  • [By ]

    It may be unhealthy to trade drug stocks Friday. The word on Wall Street is to not expect too much from President Trump’s speech on drug prices. That means expect the unexpected, and prepare for a volatility spike in key healthcare names such as Express Scripts (ESRX) , CVS Health (CVS) , Endo International (ENDP) , Mallinckrodt (MNK) , McKesson (MCK) and Cardinal Health (CAH) .

    Reports TheStreet’s Bill Meagher: “Evercore ISI may be an outlier as its analysts anticipate that recent speeches by officials from the Food and Drug Administration, Health and Human Services and Centers for Medicare & Medicaid Services may have telegraphed the Trump administration’s willingness to move beyond loud talk and tweets into policy discussions. In those tweets and in talks with his cabinet, Trump has been critical of the pharmaceutical sector and its pricing of prescription drugs, famously saying on at least two occasions that companies are “getting away with murder.”

Hot Financial Stocks To Invest In Right Now: Moneygram International, Inc.(MGI)

Advisors’ Opinion:

  • [By ]

    Moneygram (MGI) : “No, you need quality and this one doesn’t have it.”

    Monster Beverage (MNST) : “I think this one has run out of gas so I’m going to say don’t buy. “

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

Hot Financial Stocks To Invest In Right Now: Magal Security Systems Ltd.(MAGS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Magal Security Systems Ltd. (NASDAQ: MAGS) is expected to report earnings for its first quarter.

    Four Seasons Education (Cayman) Inc. (NASDAQ: FEDU) is projected to report quarterly earnings at $0.04 per share on revenue of $11.74 million.

Research Analysts’ Weekly Ratings Updates for Express Scripts (ESRX)

Several analysts have recently updated their ratings and price targets for Express Scripts (NASDAQ: ESRX):

5/17/2018 – Express Scripts was given a new $92.00 price target on by analysts at Robert W. Baird. They now have a “buy” rating on the stock. 5/11/2018 – Express Scripts was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 5/4/2018 – Express Scripts was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 5/3/2018 – Express Scripts had its price target lowered by analysts at Leerink Swann from $90.00 to $80.00. They now have a “market perform” rating on the stock. 5/3/2018 – Express Scripts had its price target lowered by analysts at Barclays from $84.00 to $83.00. They now have an “equal weight” rating on the stock. 5/2/2018 – Express Scripts was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating. 5/1/2018 – Express Scripts was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Express Scripts recently announced that its biggest customer and leading health insurer Anthem is not likely to extend its PBM agreement with Express Scripts anymore. Persistent drug pricing issue is also anticipated to affect the stock. Moreover, the company faces stiff competition, which raises concern. The company recently announced that it is getting acquired by Cigna Corporation, a global health insurance company. However, it has been benefitting from a rise in patient claims and strong customer retention. Express Scripts’ solid guidance for 2018 holds promise. Express Scripts' pharmacy-benefit management segment (PBM) coupled with recently-acquired eviCore's complementary medical-benefit solutions is likely to build a comprehensive PBM solution worldwide. In the past six months, Express Scripts has outperformed the industry in terms of price.” 4/26/2018 – Express Scripts was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 4/26/2018 – Express Scripts was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating. 4/2/2018 – Express Scripts was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.

ESRX stock opened at $76.35 on Friday. The company has a current ratio of 0.69, a quick ratio of 0.56 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $41.42 billion, a price-to-earnings ratio of 10.75, a P/E/G ratio of 0.93 and a beta of 0.98. Express Scripts has a 1 year low of $73.16 and a 1 year high of $73.65.

Get Express Scripts alerts:

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.76 by $0.01. The company had revenue of $24.77 billion for the quarter, compared to analyst estimates of $24.80 billion. Express Scripts had a return on equity of 25.41% and a net margin of 4.59%. Express Scripts’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter last year, the company earned $1.33 EPS. equities analysts forecast that Express Scripts will post 9.07 EPS for the current fiscal year.

In other Express Scripts news, insider Christine Houston sold 19,889 shares of the stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $76.69, for a total value of $1,525,287.41. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Everett Neville sold 4,895 shares of the stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of ESRX. Swedbank purchased a new position in shares of Express Scripts in the 4th quarter valued at about $111,016,000. Leucadia National Corp purchased a new position in shares of Express Scripts in the 4th quarter valued at about $567,000. Xact Kapitalforvaltning AB increased its holdings in shares of Express Scripts by 5.2% in the 4th quarter. Xact Kapitalforvaltning AB now owns 102,730 shares of the company’s stock valued at $7,668,000 after acquiring an additional 5,123 shares during the last quarter. Glenmede Trust Co. NA increased its holdings in shares of Express Scripts by 1.6% in the 4th quarter. Glenmede Trust Co. NA now owns 422,156 shares of the company’s stock valued at $31,508,000 after acquiring an additional 6,448 shares during the last quarter. Finally, Two Sigma Securities LLC purchased a new position in shares of Express Scripts in the 4th quarter valued at about $406,000. 88.20% of the stock is currently owned by institutional investors.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Hot Undervalued Stocks To Buy For 2019

Introduction

Several articles appeared in SA noting that Commerzbank AG (OTCPK:CRZBY, the ADR) could be an interesting M&A candidate. We agree with such thesis. The bank is being dramatically undervalued by the market. It is trading at half of its book value per share. In addition, its cash per share is more than ten times its current share price.

Obviously, the political conditions in Europe and the interest rates in the Eurozone are not helping the bank. Additionally, we believe that the EU may not be much interested in seeing mergers between banks. As compared to the US, the financial sector is highly consolidated.

In this article, we will provide all the good and bad reasons for executing a corporate transaction. Furthermore, we will develop several case scenarios. We will also explain how will they affect the share price.

Financial Valuations and Bank Reaction

Before we proceed further, have a look at the most significant financial stats of Commerzbank (source):

Hot Undervalued Stocks To Buy For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

  • [By Chris Neiger, Anders Bylund, and Todd Campbell]

    To help you track down a few of these companies for your portfolio, we reached out to some Motley Fool contributors for dividend stock ideas. They came back with Uniti Group (NASDAQ:UNIT), AbbVie (NYSE:ABBV), and American Tower (NYSE:AMT). Here’s why.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    So which stocks do our healthcare experts have their eye on right now? We asked these three Motley Fool investors to weigh in, and they pickedAbbVie (NYSE:ABBV),Cardinal Health (NYSE:CAH), and Masimo (NASDAQ:MASI).

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Keith Speights]

    AbbVie (NYSE:ABBV) ended 2017 with a bang, posting tremendousfourth-quarter results in January. The company has started 2018 with a bang, too.

    On Thursday, AbbVie announced its Q1 earnings results. Wall Street analysts thought the company would report revenue of $7.6 billion. AbbVie’s actual revenue total was $7.9 billion. Analysts expected adjusted earnings per share (EPS) of $1.79. AbbVie reported adjusted EPS in Q1 of $1.87.

  • [By ]

    In keeping with that philosophy, this week’s recommendation for my Income Trader subscribers was in AbbVie (NYSE: ABBV).

    Revisiting This Reliable Trade Target
    I’ve written about AbbVie a few times before. (So far, we’ve made trades on ABBV three times, and all three trades were winners.) It is one of the world’s largest drug makers (the seventh largest by market cap), known to many for its best-selling drug, Humira, a biologic therapy for autoimmune diseases including rheumatoid arthritis, Crohn’s disease and other inflammatory conditions. This is the best-selling drug in the world, with sales of more than $15 billion a year.

Hot Undervalued Stocks To Buy For 2019: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Hot Undervalued Stocks To Buy For 2019: Aehr Test Systems(AEHR)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get Aehr Test Systems alerts:

    Critical Comparison: Data I/O (DAIO) & Aehr Test Systems (AEHR) (americanbankingnews.com) Form 4 AEHR TEST SYSTEMS For: May 08 Filed by: HENDRICKSON DAVID S (streetinsider.com) Aehr Test Systems (AEHR) CTO David S. Hendrickson Sells 5,000 Shares (americanbankingnews.com) Teradyne (TER) versus Aehr Test Systems (AEHR) Head to Head Review (americanbankingnews.com) Insider Selling: Aehr Test Systems (AEHR) Insider Sells 20,000 Shares of Stock (americanbankingnews.com)

    AEHR remained flat at $$2.28 during trading hours on Monday. The company had a trading volume of 64,100 shares, compared to its average volume of 136,351. Aehr Test Systems has a 52 week low of $2.26 and a 52 week high of $2.28. The stock has a market cap of $50.06 million, a price-to-earnings ratio of -7.86 and a beta of 0.82. The company has a current ratio of 4.62, a quick ratio of 3.20 and a debt-to-equity ratio of 0.33.

Hot Undervalued Stocks To Buy For 2019: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Regeneron’s cholesterol-lowering medication Praluent was another drug with multibillion-dollar potential that’s been a huge disappointment in the commercial setting. Trying to launch a treatment with a $14,000-per-year price tag didn’t work, but a more affordable solution is getting attention from the right people. Express Scripts (NASDAQ:ESRX), a pharmacy benefits manager with a national formulary that covers around 25 million Americans, recently agreed to a straightforward reimbursement path in return for drastically lowered pricing. Express Scripts also removed Praluent’s market rival Repatha from its formulary.

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Cory Renauer]

    Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.

  • [By Alexander Bird]

    Both CVS Health Corp. (NYSE: CVS) and Cigna Corp. (NYSE: CI) sank 5% while Express Scripts Holding Co. (NASDAQ: ESRX), one of the primary providers of pharmacy benefits, dropped 9.7% in response to the disruptive impact the announced partnership could have on the industry. Altogether, the healthcare sector lost a combined $30 billion in market share in the first two hours of trading today.

  • [By Joseph Griffin]

    State of Wisconsin Investment Board boosted its stake in Express Scripts (NASDAQ:ESRX) by 25.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,092,444 shares of the company’s stock after acquiring an additional 218,855 shares during the quarter. State of Wisconsin Investment Board owned 0.19% of Express Scripts worth $75,466,000 as of its most recent filing with the SEC.

  • [By ]

    Larry Robbins and his Glenview Capital Management LLC said he is supportive of health insurance titan Cigna Corp.’s (CI) acquisition of Express Scripts Holdings Co. (ESRX) , the country’s largest benefits management group, in a deal announced in March worth $67 billion.

Hot Undervalued Stocks To Buy For 2019: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.

invest financial

Source: Offshore Energy Today

Transocean (NYSE:RIG) reported Q4 revenue of $974 million and EPS of $0.63. The company beat on revenue by $164 million. RIG closed up over 3% after earnings were released. I had the following takeaways on the quarter.

Contract Revenue Continues To Decline

Transocean’s total revenue of $974 million was up 8% sequentially and down 47% Y/Y. Its other revenue included a $169 million early termination fee for a drilling contract. Sans the early termination fee, total revenue would have been down 11% Q/Q. That said, its core contract revenue continues to decline.

invest financial: Xilinx, Inc.(XLNX)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    Further, according to recent reports, AMD, ARM (NSDQ:ARMH), Huawei Technology, International Business Machines (NYSE:IBM), Mellanox Technologies (NSDQ:MLNX), and Qualcomm (NSDQ:QCOM) have collaborated with Xilinx (NSDQ:XLNX) tobuild a homogenous interface for different CPUs to share data with FPGA accelerators, which are useful in the datacenter and deep learning space. If this collaboration is successful, it could be very bad news for Intel.

  • [By Ben Levisohn]

    Evercore ISIs CJ Muse today offers his outlook for semiconductors in 2017, writing that hes bullish because the semiconductor cycle may see a cycle in the cycle, with positive implications for several names, but for Nvidia (NVDA) and Xilinx (XLNX) in particular…

  • [By WWW.THESTREET.COM]

    Coming up in tonight’s episode of Mad Money: Cramer interviews Bill Sandbrook, CEO of U.S. Concrete (USCR)  and focuses on opportunities for Xilinx (XLNX) .  Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

invest financial: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By David Zeiler]

    Aetna is the focus of the senators’ wrath, but four of the five largest U.S. health insurers have a stake in this fight:

    No. 3 Aetna is attempting to acquire No. 5 Humana Inc. (NYSE: HUM); andNo. 2 Anthem Inc. (NYSE: ANTM) is seeking to acquire No. 4 Cigna Corp. (NYSE: CI).

    Related: Why the Cost of Obamacare Plans Will Continue to Skyrocket

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By Keith Speights]

    Although Aetna wasn’t successful in its attempted merger with Humana (NYSE:HUM), the blocked deal shouldn’t have too much residual effect. Aetna’s share price remains attractively valued, currently trading at 13 times expected earnings.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Humana Inc (NYSE: HUM).

    He said options traders were buying aggressively the January 250 calls. Around 3,200 contracts were bought in the first half of the trading session Monday and they paid $5.60 for them. The trade breaks even at $255.60 or around 5 percent higher from the current stock price.

invest financial: Ampco-Pittsburgh Corporation(AP)

Advisors’ Opinion:

  • [By ]

    New York (AP) — The bitter cold that followed a massive East Coast snowstorm should begin to lessen as temperatures inch up and climb past freezing next week, weather forecasters said.

  • [By ]

    Des Moines, Iowa (AP) — It's been a billion-dollar lottery weekend after a lone Powerball ticket sold in New Hampshire matched all six numbers and will claim a $570 million jackpot, one day after another single ticket sold in Florida nabbed a $450 million Mega Millions grand prize.

  • [By ]

    London (AP) — The British government said Sunday it is scrapping a promise to reconsider the ban on fox hunting, a centuries-old rural tradition contentiously outlawed more than a decade ago.

invest financial: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    With a neutral sector rating, we are working on evaluating risks to negative calls, and identifying potential value opportunities. Last week we noted more work might be worthwhile on Wabco Holdings (WBC), Terex, Manitowoc (MTW), and Caterpillar, two of those names have rallied for other reasons but the attractive price made the upside/downside skew up. We remain positive (OW) on Allison Transmission Holdings (ALSN) & United Rentals. Our and consensus 2017Allison Transmission Holdings estimates have fallen by 2% vs. ~15% for the group, while the shares are down 10% since launch. We continue to see United Rentals as the best value in our group…

invest financial: Dunkin' Brands Group, Inc.(DNKN)

Advisors’ Opinion:

  • [By WWW.USATODAY.COM]

    While McDonald’s (NYSE: MCD) and Dunkin’ Brands’ (NASDAQ: DNKN) Dunkin’ Donuts both now sell premium espresso-based beverages along with other fancy coffee drinks, people don’t view those brands the way they see Starbucks. The Seattle-based coffee chain exists in its own world, where it can sell out of $10 cups of whisky-barrel-aged coffee while it opens more than a thousand Reserve stores selling pricier drinks than its normal, already expensive beverage lineup.

  • [By Asit Sharma]

    Dunkin’ Brands Group, Inc. (NASDAQ:DNKN) is currently testing a concept in 300 U.S. stores that may surprise many of its investors: a streamlined menu.

  • [By Ben Levisohn]

    The market is treating Chipotle as if it is an Amazon, Tesla, Apple or Google, when in fact all they do is make burritos. With the money it would cost you to buy Chipotle today @ $14 billion dollars you could buy Wendy’s (WEN), Cheesecake Factory (CAKE), Papa John’s International (PZZA), and Dunkin’ Brands (DNKN). Chipotle would need to generate at least $24 in earnings per share in order to justify the current market cap — they are not even expected to generate half of that next year. Chipotle is expected to report Q1 on April 25 and the market, in my opinion, has already more than priced in good news.

  • [By John Udovich]

    While theMacys Thanksgiving Day parade sponsored by Macy’s, Inc (NYSE:M) is the most well known corporate sponsoredThanksgiving parade,Dunkin Brands Group Inc (NASDAQ:DNKN) and McDonald’s Corporation (NYSE:MCD) also sponsor parades in major USA cities that will help them grab some extra consumer attention and perhaps help the bottom line a bit.

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

invest financial: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Express Scripts Holding Co. (NASDAQ: ESRX) which traded down 11% at $59.98. The stocks 52-week range is $57.80 to $80.02. Volume was 35.4 million versus the daily average of 4.4 million shares.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By ]

    Express Scripts Holding (Nasdaq: ESRX) has already stated publicly that it would be open to an acquisition. The company is the largest PBM in the United States, with more than 1.4 billion adjusted claims processed annually as well as a strong home delivery pharmaceuticals service.

Top 10 Heal Care Stocks To Own Right Now

Two big events on the horizon are Federal Reserve Chairwoman Janet Yellen speaking before Congress and the launch of earnings season with reports coming out from big banks. But until those get under way, investors are paying attention to whether the tech sector can follow through with a recent gain and whether oil prices can pull out of a slump.

On Friday, stocks finished higher for the session and week on the back of a rebound in tech stocks with the Dow Jones Industrial Average
DJIA, +0.44%
rising 0.3% for the week, the S&P 500 index
SPX, +0.64%
rising less than 0.1% and the Nasdaq Composite Index
COMP, +1.04%
advancing 0.2%.

Top 10 Heal Care Stocks To Own Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

Top 10 Heal Care Stocks To Own Right Now: Pegasystems Inc.(PEGA)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares ofPegasystems Inc.(NASDAQ:PEGA) jumped 31.5% in 2016,according to data from S&P Global Market Intelligence, largely thanks to a strong quarterly report from the business management software specialist late in the year.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Snap (NYSE:SNAP) and Pegasystems (NASDAQ:PEGA) made big moves following the companies’ quarterly earnings reports.

    Image source: Getty Images.

Top 10 Heal Care Stocks To Own Right Now: Tuesday Morning Corp.(TUES)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap closeout home decor retailer Tuesday Morning Corporation (NASDAQ: TUES) reported Q4 and fiscal 2017 earnings before the market opened on Thursday. Q4net sales were $223.6 million versus $222.8 million as the Company’s sales comparison to the prior year is impacted by the net closure of 20 stores during the current fiscal year.Comparable store sales increased 1.8% compared to the same period a year ago, and were comprised of a 2.6% increase in customer transactions, partially offset by a 0.8% decrease in average ticket. The Company operated 731 stores at the end of the fiscal year, which is a decrease of 20 stores from the prior year period.The net loss was $17.3 million versusa net loss of $3.9 million.

  • [By Monica Gerson]

    Tuesday Morning (NASDAQ: TUES) shares gained 4.87% to create a new 52-week high of $14.63. Tuesday Morning shares have jumped 110.09% over the past 52 weeks, while the S&P 500 index has gained 18.17% in the same period.

Top 10 Heal Care Stocks To Own Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

Top 10 Heal Care Stocks To Own Right Now: L'Or茅al S.A. (LRLCY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    GLP’s customers include Walmart (WMT) , Unilever (UL) , JD.com (JD) , Adidas (ADDYY) , Estee Lauder (EL) and L’Oreal (LRLCY) .

    The S$3.38 offer price represents 81% premium over its 12-month volume weighted average price and a 25% premium over its last full trading day before the announcement.

  • [By SEEKINGALPHA.COM]

    Absent any debt repayment via cash flow YTD in 2017, Valeant has long term Debt of approx. $28.65B after the closing of the skincare assets to L’Oreal (OTCPK:LRLCY), and slightly under $28 Billion when the Dendreon sale to Sanpower closes and they use those proceeds to pay down debt.

  • [By SEEKINGALPHA.COM]

    Valeant’s other sale of CeraVe and several other skin care assets to L’Oreal (OTCPK:LRLCY) for $1.3B is even more spectacular. It is almost eight times the $150M Valeant spent to buy these assets between 2008 and 2012 according to this source. “Lost value” indeed. The sales price is ~20x EBITDA, showing that Valeant has received a very good price for these assets. For comparison, the beauty company Estee Lauder (NYSE:EL) trades at EV of 15x EBITDA according to Yahoo Finance.

  • [By SEEKINGALPHA.COM]

    Besides these American and Swiss titans, Unilever also faces global competition from French cosmetics giant L’Oreal (OTCPK:LRLCY) (OTCPK:LRLCF), from Colgate-Palmolive (NYSE:CL) and from Reckitt Benckiser , in the home and personal care spaces, as well as from Danone (OTCQX:DANOY), Mondelez (NASDAQ:MDLZ) and from KraftHeinz (NASDAQ:KHC) in the Big Food arena.

Top 10 Heal Care Stocks To Own Right Now: AMTEK, Inc.(AME)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

Top 10 Heal Care Stocks To Own Right Now: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Express Scripts Holding Co. (NASDAQ: ESRX) which traded down 11% at $59.98. The stocks 52-week range is $57.80 to $80.02. Volume was 35.4 million versus the daily average of 4.4 million shares.

  • [By ]

    Express Scripts Holding (Nasdaq: ESRX) has already stated publicly that it would be open to an acquisition. The company is the largest PBM in the United States, with more than 1.4 billion adjusted claims processed annually as well as a strong home delivery pharmaceuticals service.

Top 10 Heal Care Stocks To Own Right Now: Scripps Networks Interactive Inc(SNI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Scripps Networks Interactive (SNI) sunk to the bottom of the S&P 500–narrowly beating out Apartment Investment and Management (AIV)–as the parent company of the Food Network and other channels gave back a chunk of its post-elections gains.

    Getty Images

    Shares of Scripps Networks Interactive dropped 4.2% to $70.63 today, while the S&P 500 rose 0.8% to 2,180.39. Scripps had gained 13% from Nov. 8 through Nov. 14.

    Scripps reported net income of $607 million on sales of $3 billion in 2015.

    Barron’s David Englander recommended Scipps Networks’ former parent E.W. Scripps (SSP) back in August.

     

     

  • [By Lisa Levin]

    Discovery Communications Inc. (NASDAQ: DISCA) announced plans to acquire Scripps Networks Interactive, Inc. (NYSE: SNI) for $14.6 billion.

    Discovery will pay $90 per share in cash and stock to buy Scripps. The transaction is projected to close by early 2018.

Top 10 Heal Care Stocks To Own Right Now: Kamada Ltd.(KMDA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Kamada Ltd (NASDAQ: KMDA) were down 21 percent to $5.93 after the company reported the withdrawal of European Marketing Authorization Application for inhaled Alpha-1 Antitrypsin.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

Top 10 Heal Care Stocks To Own Right Now: Gladstone Land Corporation(LAND)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Gladstone Land Corp (LAND) –

    A U.S. based farmland investment company that currently offers a plus 9% annual distribution. It owns and leases farmland in Florida, California, Michigan and Oregon with appraised land value of $79 million. The distribution is paid monthly which should attract income investors.